Mihov B[au] - Search Results

Year	Number of Results
2014	2
2015	1
2016	1
2017	6
2018	2
2019	4
2020	4
2021	7
2022	6

1

Fracture Prevention with Zoledronate in Older Women with Osteopenia.

Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD. Reid IR, et al. Among authors: mihov b. N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082. Epub 2018 Oct 1. N Engl J Med. 2018. PMID: 30575489 Clinical Trial.

2

Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis.

Son CN, Stewart S, Su I, Mihov B, Gamble G, Dalbeth N. Son CN, et al. Among authors: mihov b. Semin Arthritis Rheum. 2021 Aug;51(4):677-684. doi: 10.1016/j.semarthrit.2021.04.011. Epub 2021 Apr 25. Semin Arthritis Rheum. 2021. PMID: 34139520 Free article.

3

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates.

Horne AM, Mihov B, Reid IR. Horne AM, et al. Among authors: mihov b. Calcif Tissue Int. 2018 Jul;103(1):55-61. doi: 10.1007/s00223-018-0404-6. Epub 2018 Feb 14. Calcif Tissue Int. 2018. PMID: 29445836

4

Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With Zoledronate.

Reid IR, Horne AM, Mihov B, Stewart A, Bolland MJ, Bastin S, Gamble GD. Reid IR, et al. Among authors: mihov b. J Bone Miner Res. 2021 Jan;36(1):61-66. doi: 10.1002/jbmr.4167. Epub 2020 Sep 2. J Bone Miner Res. 2021. PMID: 32835417 Free article. Clinical Trial.

5

Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up.

Horne AM, Mihov B, Reid IR. Horne AM, et al. Among authors: mihov b. Calcif Tissue Int. 2019 Jul;105(1):107-108. doi: 10.1007/s00223-019-00553-w. Epub 2019 Apr 17. Calcif Tissue Int. 2019. PMID: 31087124 No abstract available.

6

Effect of Zoledronate on Lower Respiratory Infections in Older Women: Secondary Analysis of a Randomized Controlled Trial.

Reid IR, Horne AM, Mihov B, Stewart A, Bastin S, Gamble GD. Reid IR, et al. Among authors: mihov b. Calcif Tissue Int. 2021 Jul;109(1):12-16. doi: 10.1007/s00223-021-00830-7. Epub 2021 Mar 12. Calcif Tissue Int. 2021. PMID: 33712919 Clinical Trial.

7

Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women.

Dalbeth N, Horne A, Mihov B, Stewart A, Gamble GD, Merriman TR, Stamp LK, Reid IR. Dalbeth N, et al. Among authors: mihov b. Arthritis Rheumatol. 2021 Sep;73(9):1758-1764. doi: 10.1002/art.41691. Epub 2021 Jul 16. Arthritis Rheumatol. 2021. PMID: 33586367 Clinical Trial.

8

Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women.

Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Bastin S, Gamble GD. Reid IR, et al. Among authors: mihov b. J Bone Miner Res. 2020 Jan;35(1):20-27. doi: 10.1002/jbmr.3860. Epub 2019 Oct 11. J Bone Miner Res. 2020. PMID: 31603996 Free article. Clinical Trial.

9

Bone Loss After Denosumab: Only Partial Protection with Zoledronate.

Reid IR, Horne AM, Mihov B, Gamble GD. Reid IR, et al. Among authors: mihov b. Calcif Tissue Int. 2017 Oct;101(4):371-374. doi: 10.1007/s00223-017-0288-x. Epub 2017 May 13. Calcif Tissue Int. 2017. PMID: 28500448 Clinical Trial.

10

Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.

Grey A, Horne A, Gamble G, Mihov B, Reid IR, Bolland M. Grey A, et al. Among authors: mihov b. J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgaa062. doi: 10.1210/clinem/dgaa062. J Clin Endocrinol Metab. 2020. PMID: 32016386 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results